Seiichi Mori

Seiichi Mori

Japanese Foundation for Cancer Research - Tokyo / Japan
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 4516821
財団法人がん研究振興財団
person_outline Seiichi Mori's MOST POPULAR ARTICLES
1-) Development of peripheral lymphoid organs and natural killer cells depends on the helix–loop–helix inhibitor Id2Y Yokota, A Mansouri, S Mori, S Sugawara, S Adachi, SI Nishikawa, ...Nature 397 (6721), 702-706, 199910001999
2-) Epithelial‐mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patientsTZ Tan, QH Miow, Y Miki, T Noda, S Mori, RYJ Huang, JP ThieryEMBO molecular medicine 6 (10), 1279-1293, 20145452014
3-) Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cellsT Baba, PA Convery, N Matsumura, RS Whitaker, E Kondoh, T Perry, ...Oncogene 28 (2), 209-218, 20094962009
4-) A bistable Rb–E2F switch underlies the restriction pointG Yao, TJ Lee, S Mori, JR Nevins, L YouNature cell biology 10 (4), 476-482, 20085202008
5-) An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor …RYJ Huang, MK Wong, TZ Tan, KT Kuay, AHC Ng, VY Chung, YS Chu, ...Cell death & disease 4 (11), e915-e915, 20134472013